Upcoming Webinars
February 26, 2026, 3 PM ET
Improving Oncology Outcomes Through Targeted Nutritional Assessment and Intervention
Cancer and its treatments substantially impact nutritional status and overall patient outcomes. Malnutrition and muscle loss are highly prevalent challenges that compromise treatment tolerance, increase toxicity, and diminish quality of life and survival. This presentation will highlight emerging evidence on the role of targeted nutrition strategies, emphasizing the importance of comprehensive assessment and individualized intervention. Drawing on data from clinical trials and translational research, the session will explore updated insights into energy and protein requirements in oncology, including how factors such as inflammation influence anabolic response. It will also underscore the importance of integrating nutrition into multidisciplinary cancer care to optimize outcomes across the continuum.
The EON webinar "Improving Oncology Outcomes Through Targeted Nutritional Assessment and Intervention" awards 1.0 CPEU for Commission on Dietetic Registration (CDR) credentialed practitioners in accordance with the Commission on Dietetic Registration’s CPEU Prior Approval Program.
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for physicians, physician assistants, and nurse practitioners.
April 9, 2026, 2 PM ET
Coffee consumption and improved colorectal cancer survivorship: from observational to interventional studies
Observational findings from several independent cohorts have consistently shown a beneficial association of coffee consumption after diagnosis with better survival outcomes among patients with colorectal cancer. In support of these data, coffee has been linked to lower risk of metabolic disorders, lower inflammation, and favorable blood biochemical profiles. While the components in coffee that drive these benefits remain unknown, studies of metabolomics and microbiome have identified potential molecules and mechanisms of action underlying coffee's beneficial effects. These data altogether have motivated the conduct of the first randomized control trial of coffee consumption among colorectal cancer survivors (the COMMENCER trial). In this presentation, Dr. Song will review the existing data, present the COMMENCER trial, and discuss the future directions.
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for physicians, physician assistants, and nurse practitioners.
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for physicians, physician assistants, and nurse practitioners.
Past Webinars
December 4, 2025
The CHALLENGE Trial was Positive: What's Next for the Field of Exercise Oncology?
October 23, 2025
Exercise Oncology and Oncology Nutrition research funding opportunities with AICR and ACS
The recording of this webinar session will be made available after the presenters publish their research findings.